Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
Vous n'êtes pas connecté
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.
Simon Property (SPG) is poised to benefit from its portfolio of premium assets, a focus on omnichannel retailing and strategic buyouts, though higher...
Boyd Gaming (BYD) invests in property upgrades and renovations across its portfolio to drive long-term growth. However, inflationary pressures are a...
Cintas (CTAS) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.
Globe Life (GL) stands to gain from solid performance in its Life Insurance and Health Insurance segments, strong liquidity position and favorable...
Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash...
Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash...
Starbucks (SBUX) emphasizes the rollout of the equipment-driven siren system and store optimizations to drive growth. However, macroeconomic headwinds...